Kiora Pharmaceuticals (KPRX) Revenue & Revenue Breakdown
Kiora Pharmaceuticals Revenue Highlights
Latest Revenue (Q)
$20.00K
Kiora Pharmaceuticals Revenue by Period
Kiora Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $12.06K | -99.55% |
| 2019-12-31 | $2.69M | 62.54% |
| 2018-12-31 | $1.65M | 305.51% |
| 2017-12-31 | $407.52K | -39.11% |
| 2016-12-31 | $669.26K | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | - |
Kiora Pharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Kiora Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $20.00K | -99.88% |
| 2024-03-31 | $16.00M | 5536.34% |
| 2023-12-31 | $283.87K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $12.06K | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | -100.00% |
| 2019-03-31 | $2.69M | 100.00% |
| 2018-12-31 | - | -100.00% |
| 2018-09-30 | $314.50K | 29.95% |
| 2018-06-30 | $242.01K | -77.92% |
| 2018-03-31 | $1.10M | 100.00% |
| 2017-12-31 | - | -100.00% |
| 2017-09-30 | $74.70K | -49.63% |
| 2017-06-30 | $148.29K | -19.64% |
| 2017-03-31 | $184.53K | 15.07% |
| 2016-12-31 | $160.37K | -41.53% |
| 2016-09-30 | $274.29K | 16.92% |
| 2016-06-30 | $234.60K | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | - |
Kiora Pharmaceuticals generated $20.00K in revenue during Q2 2024, up -99.88% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Kiora Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| UNCY | Unicycive Therapeutics | $675.00K | - |
| BDRX | Biodexa Pharmaceuticals | $381.00K | $41.50K |
| PALI | Palisade Bio | $250.00K | - |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| PXMD | PaxMedica | - | - |
| REVB | Revelation Biosciences | - | - |
| HILS | Tharimmune | - | - |
| ALLR | Allarity Therapeutics | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| KPRX | Kiora Pharmaceuticals | - | $20.00K |
| CDIO | Cardio Diagnostics | - | $7.87K |
| BWV | Onconetix | - | - |
KPRX Revenue FAQ
What is Kiora Pharmaceuticals’s yearly revenue?
Kiora Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. KPRX's yearly revenue for 2021 was $0, representing a decrease of -100.00% compared to 2020.
What is Kiora Pharmaceuticals’s quarterly revenue?
Kiora Pharmaceuticals's quarterly revenue for Q2 2024 was $20K, a -99.88% decrease from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $16M, a 5536.34% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). KPRX's quarterly revenue for Q4 2023 was $283.87K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Kiora Pharmaceuticals’s revenue growth rate?
Kiora Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -100.00%.